EH
EW icon

Equitable Holdings’s Edwards Lifesciences EW Stock Holding History

Equitable Holdings’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$860K Sell
9,507
-377
-4% -$31.6K 0.01% 1068
2026
Q1 		$825K Buy
9,884
+4,751
+93% +$392K 0.01% 1052
2025
Q4 		$438K Buy
5,133
+78
+2% +$6.4K ﹤0.01% 1157
2025
Q3 		$393K Sell
5,055
-26
-0.5% -$2.03K ﹤0.01% 1159
2025
Q2 		$397K Buy
5,081
+386
+8% +$28.8K ﹤0.01% 1086
2025
Q1 		$340K Buy
4,695
+846
+22% +$60.6K ﹤0.01% 1049
2024
Q4 		$285K Sell
3,849
-1,484
-28% -$104K ﹤0.01% 1059
2024
Q3 		$352K Sell
5,333
-1,772
-25% -$129K ﹤0.01% 983
2024
Q2 		$656K Sell
7,105
-36
-0.5% -$3.19K 0.01% 760
2024
Q1 		$682K Buy
7,141
+606
+9% +$50.9K 0.01% 713
2023
Q4 		$498K Sell
6,535
-1,959
-23% -$136K 0.01% 779
2023
Q3 		$588K Sell
8,494
-8,982
-51% -$722K 0.01% 669
2023
Q2 		$1.65M Buy
17,476
+6,554
+60% +$570K 0.02% 393
2023
Q1 		$904K Sell
10,922
-883
-7% -$69.4K 0.01% 494
2022
Q4 		$881K Sell
11,805
-3,369
-22% -$260K 0.02% 476
2022
Q3 		$1.25M Buy
15,174
+349
+2% +$33.6K 0.02% 355
2022
Q2 		$1.41M Sell
14,825
-4,200
-22% -$435K 0.03% 321
2022
Q1 		$2.24M Buy
19,025
+2,171
+13% +$244K 0.04% 268
2021
Q4 		$2.18M Buy
16,854
+570
+4% +$66.5K 0.03% 266
2021
Q3 		$1.84M Buy
16,284
+250
+2% +$28.5K 0.03% 276
2021
Q2 		$1.66M Sell
16,034
-9,150
-36% -$862K 0.03% 283
2021
Q1 		$2.11M Sell
25,184
-1,095
-4% -$92.6K 0.04% 236
2020
Q4 		$2.4M Sell
26,279
-1,816
-6% -$151K 0.05% 202
2020
Q3 		$2.24M Buy
28,095
+1,399
+5% +$109K 0.06% 189
2020
Q2 		$1.84M Buy
26,696
+7,250
+37% +$515K 0.05% 222
2020
Q1 		$1.22M Buy
19,446
+6,078
+45% +$438K 0.04% 238
2019
Q4 		$1.04M Buy
+13,368
New +$1.04M 0.03% 296

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Equitable Holdings's EW Position: Q2 2026 in Review

Equitable Holdings reduced its Edwards Lifesciences (EW) stake by 3.8% in Q2 2026, selling an estimated $31.6K and leaving 9,507 shares worth $860K. The position accounts for 0.01% of the portfolio, ranked #1068.

Equitable Holdings first reported a position in EW in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.4M in Q4 2020. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Equitable Holdings held 9,507 shares of Edwards Lifesciences worth $860K as of Q2 2026.
  • Equitable Holdings sold 377 Edwards Lifesciences shares in Q2 2026, an estimated $31.6K.
  • Edwards Lifesciences made up 0.01% of Equitable Holdings's portfolio in Q2 2026, its #1068 holding.
  • Equitable Holdings first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 27 quarters since.
  • Equitable Holdings's Edwards Lifesciences position peaked at $2.4M in Q4 2020.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.